Home » Authors » Omar Ford

Articles by Omar Ford

Deals roundup: Exactech adds Altiva for $25M; Polyone completes buy of GLS

Jan. 4, 2008

BD's new FDA-cleared MRSA test gives results in 2 hours

Jan. 3, 2008

AHIP says with 3-part plan, no one will fall 'between the cracks'

Jan. 1, 2008

Cancer drug is used by Angiotech as new CVC anti-infective

Jan. 1, 2008

Boston Sci gets CE mark for Livian CRT-D Device

Dec. 31, 2007

I-Flow buying AcryMed for $25M; NeuroMetrix purchases EyeTel

Dec. 28, 2007

AHIP says with its 3-part plan none 'falls between the cracks'

Dec. 21, 2007

New venture: Wood ‘sees’ ArcScan’s future in Artemis ultrasound device

Dec. 20, 2007

Angiotech using cancer drug as anti-infective CVC coating

Dec. 20, 2007

Wood sees ArcScan s future in Artemis ultrasound device

Dec. 14, 2007

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...